Founder

Dimitrios Stamou, PhD

Dimitrios is a Professor in the Department of Chemistry at the University of Copenhagen and Director of the Center for Geometrical Engineering of Cellular Systems. For the past 25 years his laboratory has been developing disruptive technologies that hold the potential to revolutionise the discovery process for transporters and GPCRs.

Advisory Board

Georgios Skiniotis, PhD

Georgios is Professor of Structural Biology and Molecular & Cellular Physiology at Stanford University and Director of the Stanford CryoEM Center. His laboratory seeks to resolve structural and mechanistic questions underlying biological processes that are central to cellular physiology.

Marta Filizola, PhD

Marta is the Sharon & Frederick A. Klingenstein-Nathan G. Kase, MD Professor and the Dean of the Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai. She is a dedicated leader in computational biophysics of membrane proteins with over 20 years of experience in the application of methods of computational and theoretical chemistry to biochemical and biomedical problems, as well as to rational drug design. Filizola laboratory.

Elias Papatheodorou, BSc

Elias brings close to 30 years of international work experience, 23 of these in the life sciences industry. He has been involved at C-level positions with Covagen (acquired by JnJ), Genkyotex (acquired by Calliditas), Novosom (acquired by Marina Biotech) and with Medigene (MDG1). He is currently the Chair of the Board of Memo Therapeutics (Zurich), Heparegenix (Tubingen) and Board Member of Tribune Therapeutics  (Oslo/Stockholm). Linkedin.

Christoph Bieri, PhD

Christoph is a seasoned strategy and M&A advisor with deep experience in the life science industry. In various firms and roles, Christoph has provided M&A and strategy advise to owner-managed businesses since 2007. From 2020 to 2022 he reorganized Switzerland’s longest-established VC firm and set its new strategic direction. Prior to that, he built a global mid-market M&A firm focused on Pharma and Med-Tech deals which was acquired by EY in 2019. Between 2002 and 2006, he co-founded and ran Covalys Biosciences AG which commercialised the SNAP/HALO protein tag technology. Christoph started his career at The Boston Consulting Group after completing a PhD in Biophysics at EPF Lausanne studying GPCR/G Protein interactions. Linkedin.